Boston Scientific has sold its stake in the Houston-based implantable-device company Cyberonics. The Natick, Mass., devicemaker unloaded 3.57 million shares of Cyberonicsa 13.3% stake, according to published reportsat $13.60 per share, for a total of $48.6 million.
The sale is the most recent move in Boston Scientifics efforts to divest itself of nonstrategic assets.
Over the past three months, the devicemaker has moved to sell its fluid-management business as well as its cardiac- and vascular-surgery divisions. -- by Shawn Rhea
What do you think? Post a comment on this article and share your opinion with other readers. Submit your letter to Modern Healthcare Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.